HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics

Retrovirology

Volumn 10, Issue 1, 2013, Pages

  Abecasis, Ana B ^a   Wensing, Annemarie M J ^b   Paraskevis, Dimitris ^c   Vercauteren, Jurgen ^d,e   Theys, Kristof ^d   Van de Vijver, David A M C ^f   Albert, Jan ^g,h   Asjö, Birgitta ⁱ   Balotta, Claudia ^j   Beshkov, Danail ^k   Camacho, Ricardo J ^a,l   Clotet, Bonaventura ^m   De Gascun, Cillian ⁿ   Griskevicius, Algis ^o   Grossman, Zehava ^p   Hamouda, Osamah ^q   Horban, Andrzej ^r   Kolupajeva, Tatjana ^s   Korn, Klaus ^t   Kostrikis, Leon G ^u   Kücherer, Claudia ^q   Liitsola, Kirsi ^v   Linka, Marek ^w   Nielsen, Claus ^x   Otelea, Dan ^y   Paredes, Roger ^m   Poljak, Mario ^z   Puchhammer Stöckl, Elisabeth ^aa   Schmit, Jean Claude ^ab,ac   Sönnerborg, Anders ^g   Stanekova, Danika ^ad   Stanojevic, Maja ^ae   Struck, Daniel ^ab   Boucher, Charles A B ^f   Vandamme, Anne Mieke ^a,d   more..

^a INSTITUTO DE HIGIENE E MEDICINA TROPICAL   (Portugal)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^e UNIVERSITY OF ANTWERP   (Belgium)

^f ERASMUS MEDICAL CENTER   (Netherlands)

^g KAROLINSKA INSTITUTE   (Sweden)

^h KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

ⁱ UNIVERSITY OF BERGEN   (Norway)

^j UNIVERSITY OF MILAN   (Italy)

^k NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

^l HOSPITAL EGAS MONIZ   (Portugal)

^m HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

ⁿ UNIVERSITY COLLEGE DUBLIN   (Ireland)

^o National Public Health Surveillance Laboratory   (Lithuania)

^p TEL AVIV UNIVERSITY   (Israel)

^q ROBERT KOCH INSTITUTE   (Germany)

^r MEDICAL UNIVERSITY OF WARSAW   (Poland)

^s Infectology Center of Latvia   (Latvia)

^t UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^u UNIVERSITY OF CYPRUS   (Cyprus)

^v NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^w NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^x STATENS SERUM INSTITUT   (Denmark)

^y Prof Dr Matei Bals Institute for Infectious Diseases   (Romania)

^z UNIVERSITY OF LJUBLJANA   (Slovenia)

^aa MEDICAL UNIVERSITY OF VIENNA   (Austria)

^ab LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

^ac CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^ad SLOVAK MEDICAL UNIVERSITY   (Slovakia)

^ae UNIVERSITY OF BELGRADE   (Serbia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMINO ACID SEQUENCE; ARTICLE; CLADISTICS; COMPUTER PROGRAM; DEMOGRAPHY; EPIDEMIC; EUROPE; FEMALE; GENETIC RECOMBINATION; HETEROSEXUALITY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMIGRANT; INTRAVENOUS DRUG ABUSE; ISRAEL; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC TREE; POLAND; PORTUGAL; SEX DIFFERENCE; SLOVENIA; VIRUS TRANSMISSION; VIRUS TYPING;

BAYES THEOREM; EPIDEMICS; EUROPE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; RISK FACTORS; RISK-TAKING; SOCIAL BEHAVIOR; SOCIOECONOMIC FACTORS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84872127915     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-10-7     Document Type: Article

References (42)

1. Gao F, Bailes E, Robertson DL, Chen Y, Rodenburg CM, Michael SF, Cummins LB, Arthur LO, Peeters M, Shaw GM, et al. Origin of HIV-1 in Pan troglodytes troglodytes. Nature 1999, 397:436-441. 10.1038/17130, 9989410.
2. Plantier JC, Leoz M, Dickerson JE, De Oliveira F, Cordonnier F, Lemée V, Damond F, Robertson DL, Simon F. A new human immunodeficiency virus derived from gorillas. Nat Med 2009, 15:871-872. 10.1038/nm.2016, 19648927.
3. Sharp PM, Bailes E, Chaudhuri RR, Rodenburg CM, Santiago MO, Hahn BH. The origins of acquired immune deficiency syndrome viruses: where and when?. Philos Trans R Soc Lond B Biol Sci 2001, 356:867. 10.1098/rstb.2001.0863, 1088480, 11405934.
4. Van Heuverswyn F, Li Y, Neel C, Bailes E, Keele BF, Liu W, Loul S, Butel C, Liegeois F, Bienvenue Y, et al. Human immunodeficiency viruses: SIV infection in wild gorillas. Nature 2006, 444:164. 10.1038/444164a, 17093443.
5. Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, Funkhouser RK, Gao F, Hahn BH, Kalish ML, Kuiken C, et al. HIV-1 nomenclature proposal. Science 2000, 288:55-55.
6. Abecasis AB, Deforche K, Snoeck J, Bacheler LT, McKenna P, Carvalho AP, Gomes P, Camacho RJ, Vandamme AM. Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C. F or G. Aids 2005, 19:1799.
7. Abecasis AB, Vandamme AM, Lemey P. Quantifying differences in the tempo of human immunodeficiency virus type 1 subtype evolution. J Virol 2009, 83:12917. 10.1128/JVI.01022-09, 2786833, 19793809.
8. Abecasis AB, Deforche K, Bacheler LT, McKenna P, Carvalho AP, Gomes P, Vandamme AM, Camacho RJ. Investigation of baseline susceptibility to protease inhibitors in HIV-1 subtypes C, F, G and CRF02_AG. Antivir Ther 2006, 11:581.
9. Camacho RJ, Vandamme AM. Antiretroviral resistance in different HIV-1 subtypes: impact on therapy outcomes and resistance testing interpretation. Curr Opin HIV AIDS 2007, 2:123. 10.1097/COH.0b013e328029824a, 19372877.
10. Brenner B, Turner D, Oliveira M, Moisi D, Detorio M, Carobene M, Marlink RG, Schapiro J, Roger M, Wainberg MA. A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors. AIDS 2003, 17:F1. 10.1097/00002030-200301030-00001, 12478089.
11. Grossman Z, Paxinos EE, Averbuch D, Maayan S, Parkin NT, Engelhard D, Lorber M, Istomin V, Shaked Y, Mendelson E, et al. Mutation D30N is not preferentially selected by human immunodeficiency virus type 1 subtype C in the development of resistance to nelfinavir. Antimicrob Agents Chemother 2004, 48:2159. 10.1128/AAC.48.6.2159-2165.2004, 415604, 15155216.
12. Palma AC, Covens K, Snoeck J, Vandamme A-M, Camacho RJ, Van Laethem K. HIV-1 protease mutation 82M contributes to phenotypic resistance to protease inhibitors in subtype G. J Antimicrob Chemother 2012, 67:1075-1079. 10.1093/jac/dks010, 22331593.
13. van de Vijver DA, Wensing AMJ, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix M-L, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A, Horban A, Korn K, Kücherer C, Leitner T, Loveday C, MacRae E, Maljkovic I, de Mendoza C, Meyer L, Nielsen C, Op de Coul ELM, Ormaasen V, Paraskevis D, Perrin L, Puchhammer-Stöckl E, Ruiz L, Salminen M, Schmit J-C, Schneider F, Schuurman R, Soriano V, Stanczak G, Stanojevic M, Vandamme A-M, Van Laethem K, Violin M, Wilbe K, Yerly S, Zazzi M, Boucher CAB. The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes. J Acquir Immune Defic Syndr 2006, 41:352-360. 10.1097/01.qai.0000209899.05126.e4, 16540937.
14. Baeten JM, Chohan B, Lavreys L, Chohan V, McClelland RS, Certain L, Mandaliya K, Jaoko W, Julie O. HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis 2007, 195:1177. 10.1086/512682, 17357054.
15. Kiwanuka N, Laeyendecker O, Robb M, Kigozi G, Arroyo M, McCutchan F, Eller LA, Eller M, Makumbi F, Birx D, et al. Effect of human immunodeficiency virus type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. J Infect Dis 2008, 197:707. 10.1086/527416, 18266607.
16. Renjifo B, Gilbert P, Chaplin B, Msamanga G, Mwakagile D, Fawzi W, Essex M, et al. Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D. AIDS 2004, 18:1629. 10.1097/01.aids.0000131392.68597.34, 15280773.
17. Yang C, Li M, Newman RD, Shi Y-P, Ayisi J, van Eijk AM, Otieno J, Misore AO, Steketee RW, Nahlen BL, Lal RB. Genetic diversity of HIV-1 in western Kenya: subtype-specific differences in mother-to-child transmission. AIDS 2003, 17:1667-1674. 10.1097/00002030-200307250-00011, 12853749.
18. Geretti AM, Harrison L, Green H, Sabin C, Hill T, Fearnhill E, Pillay D, Dunn D. on behalf of the UK Collaborative Group on HIV Drug Resistance and the UK Collaborative HIV Cohort Study: Effect of HIV-1 Subtype on Virologic and Immunologic Response to Starting Highly Active Antiretroviral Therapy. Clin Infect Dis 2009, 48:1296-1305. 10.1086/598502, 19331585.
19. John-Stewart GC, Nduati RW, Rousseau CM, Mbori-Ngacha DA, Richardson BA, Rainwater S, Panteleeff DD, Overbaugh J. Subtype C Is Associated with Increased Vaginal Shedding of HIV-1. J Infect Dis 2005, 192:492-496. 10.1086/431514, 3387274, 15995964.
20. Buonaguro L, Tornesello ML, Buonaguro FM. Human immunodeficiency virus type 1 subtype distribution in the worldwide epidemic: pathogenetic and therapeutic implications. J Virol 2007, 81:10209. 10.1128/JVI.00872-07, 2045484, 17634242.
21. Gaschen B, Taylor J, Yusim K, Foley B, Gao F, Lang D, Novitsky V, Haynes B, Hahn BH, Bhattacharya T, et al. Diversity considerations in HIV-1 vaccine selection. Science 2002, 296:2354. 10.1126/science.1070441, 12089434.
22. Nickle DC, Rolland M, Jensen MA, Pond SL, Deng W, Seligman M, Heckerman D, Mullins JI, Jojic N. Coping with viral diversity in HIV vaccine design. PLoS Comput Biol 2007, 3:e75. 10.1371/journal.pcbi.0030075, 1857809, 17465674.
23. Hemelaar J, Gouws E, Ghys PD, Osmanov S. WHO-UNAIDS Network for HIV Isolation and Characterisation: Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 2011, 25:679. 10.1097/QAD.0b013e328342ff93, 21297424.
24. Bannister WP, Ruiz L, Loveday C, Vella S, Zilmer K, KJOER J, Knysz B, Phillips AN, Mocroft A, Lundgren JD. HIV-1 subtypes and response to combination antiretroviral therapy in Europe. Antivir Ther 2006, 11:707-715.
25. Vercauteren J, Wensing AMJ, van de Vijver DAMC, Albert J, Balotta C, Hamouda O, Kücherer C, Struck D, Schmit J-C, Asjö B, Bruckova M, Camacho RJ, Clotet B, Coughlan S, Grossman Z, Horban A, Korn K, Kostrikis L, Nielsen C, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Riva C, Ruiz L, Salminen M, Schuurman R, Sonnerborg A, Stanekova D, Stanojevic M, Vandamme A-M, Boucher CAB. Transmission of drug-resistant HIV-1 is stabilizing in Europe. J Infect Dis 2009, 200:1503-1508. 10.1086/644505, 19835478.
26. The SPREAD. Programme: Transmission of drug-resistant HIV-1 in Europe remains limited to single classes. AIDS 2008, 22:625-635.
27. Fox J, Castro H, Kaye S, McClure M, Weber JN, Fidler S. Epidemiology of non-B clade forms of HIV-1 in men who have sex with men in the UK. AIDS 2010, 24:2397-2401.
28. Palma AC, Araújo F, Duque V, Borges F, Paixão MT, Camacho R. Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal. Infect Genet Evol 2007, 7:391-398. 10.1016/j.meegid.2007.01.009, 17360244.
29. Paraskevis D, Magiorkinis E, Magiorkinis G, Sypsa V, Paparizos V, Lazanas M, Gargalianos P, Antoniadou A, Panos G, Chrysos G, Sambatakou H, Karafoulidou A, Skoutelis A, Kordossis T, Koratzanis G, Theodoridou M, Daikos G, Nikolopoulos G, Pybus O, Hatzakis A. Increasing Prevalence of HIV-1 Subtype A in Greece: Estimating Epidemic History and Origin. J Infect Dis 2007, 196:1167-1176. 10.1086/521677, 17955435.
30. van Veen MG, Presanis AM, Conti S, Xiridou M, Stengaard AR, Donoghoe MC, van Sighem AI, Van Der Sande MA, De Angelis D. National estimate of HIV prevalence in the Netherlands: comparison and applicability of different estimation tools. AIDS 2011, 25:229-237. 10.1097/QAD.0b013e32834171bc, 21150562.
31. Abecasis AB, Wang Y, Libin P, Imbrechts S, de Oliveira T, Camacho RJ, Vandamme AM. Comparative performance of the REGA subtyping tool version 2 versus version 1. Infect Genet Evol 2010, 10:380-385. 10.1016/j.meegid.2009.09.020, 19822224.
32. Yebra G, de Mulder M, Martín L, Pérez-Cachafeiro S, Rodríguez C, Labarga P, García F, Tural C, Jaén A, Navarro G, Holguín A. Sensitivity of seven HIV subtyping tools differs among subtypes/recombinants in the Spanish cohort of naïve HIV-infected patients (CoRIS). Antiviral Res 2011, 89:19-25. 10.1016/j.antiviral.2010.10.008, 21070813.
33. UNAIDS Collaborating Centre on AIDS HIV/AIDS Surveillance in Europe. End-year report 2003, UNAIDS Collaborating Centre on AIDS.
34. Gottlieb MS, Schroff R, Schanker HM, Weisman JD, Fan PT, Wolf RA, Saxon A. Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men. N Engl J Med 1981, 305:1425-1431. 10.1056/NEJM198112103052401, 6272109.
35. Masur H, Michelis MA, Greene JB, Onorato I, Vande Stouwe RA, Holzman RS, Wormser G, Brettman L, Lange M, Murray HW, et al. An outbreak of community-acquired Pneumocystis carinii pneumonia. N Engl J Med 1981, 305:1431-1438. 10.1056/NEJM198112103052402, 6975437.
36. Kiwanuka N, Laeyendecker O, Quinn TC, Wawer MJ, Shepherd J, Robb M, Kigozi G, Kagaayi J, Serwadda D, Makumbi FE, Reynolds SJ, Gray RH. HIV-1 subtypes and differences in heterosexual HIV transmission among HIV-discordant couples in Rakai. Uganda. AIDS 2009, 23:2479-2484.
37. Kunanusont C, Foy HM, Kreiss JK, Rerks-Ngarm S, Phanuphak P, Raktham S, Pau CP, Young NL. HIV-1 subtypes and male-to-female transmission in Thailand. Lancet 1995, 345:1078-1083. 10.1016/S0140-6736(95)90818-8, 7715340.
38. De Oliveira T, Deforche K, Cassol S, Salminen M, Paraskevis D, Seebregts C, Snoeck J, Van Rensburg EJ, Wensing AM, Van De Vijver DA, Boucher CAB, Camacho RJ, Vandamme AM. An automated genotyping system for analysis of HIV-1 and other microbial sequences. Bioinformatics 2005, 21:3797. 10.1093/bioinformatics/bti607, 16076886.
39. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673. 10.1093/nar/22.22.4673, 308517, 7984417.
40. Rambaut A. Se-Al: Sequence Alignment Editor 1996,
41. Team R. R: A language and environment for statistical computing. R Foundation for Statistical Computing Vienna Austria ISBN 2008, 3.
42. Heckerman D. A tutorial on learning with Bayesian networks 1998, Kluwer Academic Publishers, In Learning in graphical models.